Replies to post #3892496 on BB's Stock Haven

[MakingThatMoney]

FARE - NEW YORK, NY -- (Marketwired) -- 01/19/16 -- World Moto, Inc. (OTC: FARE) (BERLIN: WM7) (BERLIN: A1J8SY) ("World Moto" or the "Company"), a leader in advanced solutions for motorcycle taxis and on-demand transport, today announced that it has signed a memorandum of understanding with a distributor in Kampala for sales support of the Moto-Meter™ throughout Uganda.

The MOU authorizes the Kampala distributor of retail and consumer merchandise to immediately begin marketing the Moto-Meter™ in the assigned territory as an authorized partner of World Moto, and allows him to purchase the Moto-Meter™ at a specified price, with preferred lead times for orders of initial stock.

Kampala City has an estimated 250,000 motorcycle taxis (Source: The Guardian, 2013), and a recent objective of Kamapala City's Council Authority is to have all moto taxis, called bodabodas, within the city limits to be registered and issued an official license to operate. To date, 53,000 bodabodas have registered with the Council Authority, and the process is ongoing. The Council Authority is currently discussing the options for new regulations regarding the safe use of motorcycle taxis throughout the city, with collaboration from the distributor on the unique merits of the Moto-Meter™.

Company CEO Paul Giles stated, "Distributors are a highly effective way to reach not only customers, but state and municipal governments. Recent movements in India and Uganda are just two examples of the initiatives being undertaken by authorities around world to professionalize the motorcycle taxi industry, and it is World Moto's distributors and channel partners that are going to be driving sales throughout this transformation."

[cjstocksup]

XTNT $2.60 HUGE recent FDA News~ Xtant Medical Announces FDA Clearance of the Xspan(TM) Laminoplasty Fixation System

7:30 AM ET 3/30/16 | GlobeNewswire

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, X-spine Systems, received FDA clearance of the Xspan(TM) Laminoplasty Fixation System.

About the Xspan(TM) Laminoplasty Fixation System

The Xspan(TM) System represents the latest generation of laminoplasty fixation. Spinal laminoplasty is a surgical procedure performed to remove pressure from the spinal cord. Unlike a laminectomy, where the entire lamina is removed, only an opening or window is made on one side of the lamina to alleviate the compression of the spinal cord. The lamina is then restructured by a small plate which allows the spinal canal to increase in size without losing stability or movement in the vertebrae. This procedure can be completed at single or multiple levels.

The Xspan(TM) Laminoplasty Fixation System is intended for use in the lower cervical and upper thoracic spine (C3-T3). "We are very pleased to have received clearance for Xspan," stated Dr. David Kirschman, CSO, EVP, and Director of Xtant Medical. "This system will allow Xtant Medical to further differentiate itself from the competition and will better serve the growing needs of our surgeon partners."

Xtant Medical estimates the world wide market for laminoplasty at $110M and growing. Xspan will be available to a limited number of key surgeons in the second fiscal quarter of 2016, with a larger general release to follow later in 2016.

About Xtant Medical Holdings

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets. For further information, please visit www.xtantmedical.com.